Chen Minhua: crystal research in the development of generic pharmaceutical products

From June 29, 2018 to June 30, 2018, under the guidance of China Pharmaceutical University, Chongqing Municipal Economic and Information Commission, sponsored by pharma.com and China Pharmacy magazine, and organized by Chongqing Kangzhou pharmaceutical big data development and Application Research Institute, Pharma elite club and pharma college, the third China Pharmaceutical R & D · innovation summit and 2018 top 100 list of China's pharmaceutical R & D strength will be released in Chongqing At the grand opening of Marriott Hotel, Dr Chen Minhua will attend and deliver a keynote speech: Guest Speaker: Dr Chen Minhua, expert of national "thousand talents plan" and President of Suzhou Jingyun Pharmaceutical Technology Co., Ltd Dr Chen Minhua is a Bachelor of chemistry from Peking University and a doctor of chemistry from New Jersey State University Prior to the founding of Jingyun, Chen Minhua had 8 years of drug R & D and production experience in Merck pharmaceutical company in the United States, and was familiar with all stages of new drugs from pre clinical R & D to market Chen is specialized in drug crystal, eutectic and salt type screening, solid-state analysis, crystal resolution of chiral molecules and application of Nano Engineering in drug delivery Chen Minhua has published 20 articles in international scientific journals, is the inventor of more than 30 international patents, and has made more than 20 reports in various large international conferences Lecture Title: crystal research in the development of generic pharmaceutical products: 1 Crystal background 2 The significance of crystal research 3 The influence of crystal on drug properties 4 The importance of crystal research in preparations 5 Screening, evaluation and selection of new drug solid form 6 Sharing of metastable crystal development examples 7 More details of crystal cloud and crystal research conference, please click [heavyweight] "The third China Pharmaceutical R & D Innovation Summit and 2018 top 100 list of China's pharmaceutical R & D strength" will be held soon!